247 related articles for article (PubMed ID: 18390835)
1. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
Han S; Ritzenthaler JD; Zheng Y; Roman J
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta.
Han S; Ritzenthaler JD; Wingerd B; Roman J
J Biol Chem; 2005 Sep; 280(39):33240-9. PubMed ID: 16061473
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
7. Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha.
Sun X; Ritzenthaler JD; Zhong X; Zheng Y; Roman J; Han S
Cancer Res; 2009 Aug; 69(16):6445-53. PubMed ID: 19654299
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
Péchery A; Fauconnet S; Bittard H; Lascombe I
Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
[TBL] [Abstract][Full Text] [Related]
9. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
Ritzenthaler JD; Roman J; Han S
Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop.
Kim S; Domon-Dell C; Kang J; Chung DH; Freund JN; Evers BM
J Biol Chem; 2004 Feb; 279(6):4285-91. PubMed ID: 14623898
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.
Sharma AK; Sk UH; He P; Peters JM; Amin S
Bioorg Med Chem Lett; 2010 Jul; 20(14):4050-2. PubMed ID: 20542425
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.
Pedchenko TV; Gonzalez AL; Wang D; DuBois RN; Massion PP
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):689-96. PubMed ID: 18566335
[TBL] [Abstract][Full Text] [Related]
14. PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.
Kim WJ; Lee W; Jung Y; Jang HJ; Kim YK; Kim SN
Biochem Biophys Res Commun; 2019 Mar; 510(4):621-628. PubMed ID: 30739791
[TBL] [Abstract][Full Text] [Related]
15. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
17. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
[TBL] [Abstract][Full Text] [Related]
18. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
20. PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.
Gu L; Shi Y; Xu W; Ji Y
Oncol Res; 2019 Aug; 27(8):923-933. PubMed ID: 30982495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
